Cargando…
Generation of human colon organoids from healthy and inflammatory bowel disease mucosa
Ulcerative colitis and Crohn’s disease are chronic inflammatory bowel diseases (IBD) of unknown cause characterized by a relapsing-remitting behavior. Growing evidence supports the idea that the epithelial barrier plays a central role in the pathogenesis of IBD as well as in its evolution over time,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612551/ https://www.ncbi.nlm.nih.gov/pubmed/36301950 http://dx.doi.org/10.1371/journal.pone.0276195 |
_version_ | 1784819797422243840 |
---|---|
author | Dotti, Isabella Mayorgas, Aida Salas, Azucena |
author_facet | Dotti, Isabella Mayorgas, Aida Salas, Azucena |
author_sort | Dotti, Isabella |
collection | PubMed |
description | Ulcerative colitis and Crohn’s disease are chronic inflammatory bowel diseases (IBD) of unknown cause characterized by a relapsing-remitting behavior. Growing evidence supports the idea that the epithelial barrier plays a central role in the pathogenesis of IBD as well as in its evolution over time, thus representing a potential target for novel therapeutic options. In the last decade, the introduction of 3D epithelial cultures from ex vivo-expanded intestinal adult stem cells (ASCs) has impacted our ability to study the function of the epithelium in several gastrointestinal disorders, including IBD. Here, we describe in detail a reproducible protocol to generate Matrigel-embedded epithelial organoids from ASCs of non-IBD and IBD donors using small colonic biopsies, including steps for its optimization. A slightly modified version of this protocol is also provided in case surgical samples are used. With this method, epithelial organoids can be expanded over several passages, thereby generating a large quantity of viable cells that can be used in multiple downstream analyses including genetic, transcriptional, proteomic and/or functional studies. In addition, 3D cultures generated using our protocol are suitable for the establishment of 2D cultures, which can model relevant cell-to-cell interactions that occur in IBD mucosa. |
format | Online Article Text |
id | pubmed-9612551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-96125512022-10-28 Generation of human colon organoids from healthy and inflammatory bowel disease mucosa Dotti, Isabella Mayorgas, Aida Salas, Azucena PLoS One Lab Protocol Ulcerative colitis and Crohn’s disease are chronic inflammatory bowel diseases (IBD) of unknown cause characterized by a relapsing-remitting behavior. Growing evidence supports the idea that the epithelial barrier plays a central role in the pathogenesis of IBD as well as in its evolution over time, thus representing a potential target for novel therapeutic options. In the last decade, the introduction of 3D epithelial cultures from ex vivo-expanded intestinal adult stem cells (ASCs) has impacted our ability to study the function of the epithelium in several gastrointestinal disorders, including IBD. Here, we describe in detail a reproducible protocol to generate Matrigel-embedded epithelial organoids from ASCs of non-IBD and IBD donors using small colonic biopsies, including steps for its optimization. A slightly modified version of this protocol is also provided in case surgical samples are used. With this method, epithelial organoids can be expanded over several passages, thereby generating a large quantity of viable cells that can be used in multiple downstream analyses including genetic, transcriptional, proteomic and/or functional studies. In addition, 3D cultures generated using our protocol are suitable for the establishment of 2D cultures, which can model relevant cell-to-cell interactions that occur in IBD mucosa. Public Library of Science 2022-10-27 /pmc/articles/PMC9612551/ /pubmed/36301950 http://dx.doi.org/10.1371/journal.pone.0276195 Text en © 2022 Dotti et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Lab Protocol Dotti, Isabella Mayorgas, Aida Salas, Azucena Generation of human colon organoids from healthy and inflammatory bowel disease mucosa |
title | Generation of human colon organoids from healthy and inflammatory bowel disease mucosa |
title_full | Generation of human colon organoids from healthy and inflammatory bowel disease mucosa |
title_fullStr | Generation of human colon organoids from healthy and inflammatory bowel disease mucosa |
title_full_unstemmed | Generation of human colon organoids from healthy and inflammatory bowel disease mucosa |
title_short | Generation of human colon organoids from healthy and inflammatory bowel disease mucosa |
title_sort | generation of human colon organoids from healthy and inflammatory bowel disease mucosa |
topic | Lab Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612551/ https://www.ncbi.nlm.nih.gov/pubmed/36301950 http://dx.doi.org/10.1371/journal.pone.0276195 |
work_keys_str_mv | AT dottiisabella generationofhumancolonorganoidsfromhealthyandinflammatoryboweldiseasemucosa AT mayorgasaida generationofhumancolonorganoidsfromhealthyandinflammatoryboweldiseasemucosa AT salasazucena generationofhumancolonorganoidsfromhealthyandinflammatoryboweldiseasemucosa |